» Articles » PMID: 35535866

Interplay of SOX Transcription Factors and MicroRNAs in the Brain Under Physiological and Pathological Conditions

Overview
Date 2022 May 10
PMID 35535866
Authors
Affiliations
Soon will be listed here.
Abstract

Precise tuning of gene expression, accomplished by regulatory networks of transcription factors, epigenetic modifiers, and microRNAs, is crucial for the proper neural development and function of the brain cells. The SOX transcription factors are involved in regulating diverse cellular processes during embryonic and adult neurogenesis, such as maintaining the cell stemness, cell proliferation, cell fate decisions, and terminal differentiation into neurons and glial cells. MicroRNAs represent a class of small non-coding RNAs that play important roles in the regulation of gene expression. Together with other gene regulatory factors, microRNAs regulate different processes during neurogenesis and orchestrate the spatial and temporal expression important for neurodevelopment. The emerging data point to a complex regulatory network between SOX transcription factors and microRNAs that govern distinct cellular activities in the developing and adult brain. Deregulated SOX/microRNA interplay in signaling pathways that influence the homeostasis and plasticity in the brain has been revealed in various brain pathologies, including neurodegenerative disorders, traumatic brain injury, and cancer. Therapeutic strategies that target SOX/microRNA interplay have emerged in recent years as a promising tool to target neural tissue regeneration and enhance neurorestoration. Numerous studies have confirmed complex interactions between microRNAs and SOX-specific mRNAs regulating key features of glioblastoma. Keeping in mind the crucial roles of SOX genes and microRNAs in neural development, we focus this review on SOX/microRNAs interplay in the brain during development and adulthood in physiological and pathological conditions. Special focus was made on their interplay in brain pathologies to summarize current knowledge and highlight potential future development of molecular therapies.

Citing Articles

Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities.

Li J, Xu Y, Han Y, Yang A, Qian M, Wang B Medicine (Baltimore). 2025; 104(5):e41393.

PMID: 39889187 PMC: 11789896. DOI: 10.1097/MD.0000000000041393.


Unraveling the mechanisms of glioblastoma's resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs.

Alshammari Q, Alshammari S, Alshammari A, Alfarhan M, Baali F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39476245 DOI: 10.1007/s00210-024-03564-z.


Stage-specific expression patterns and co-targeting relationships among miRNAs in the developing mouse cerebral cortex.

Todorov H, Weissbach S, Schlichtholz L, Mueller H, Hartwich D, Gerber S Commun Biol. 2024; 7(1):1366.

PMID: 39433948 PMC: 11493953. DOI: 10.1038/s42003-024-07092-7.


The Role of SOX Transcription Factors in Ageing and Age-Related Diseases.

Stevanovic M, Lazic A, Schwirtlich M, Stanisavljevic Ninkovic D Int J Mol Sci. 2023; 24(1).

PMID: 36614288 PMC: 9821406. DOI: 10.3390/ijms24010851.


The Role of Epigenetics in Neuroinflammatory-Driven Diseases.

Giallongo S, Longhitano L, Denaro S, DAprile S, Torrisi F, La Spina E Int J Mol Sci. 2022; 23(23).

PMID: 36499544 PMC: 9740629. DOI: 10.3390/ijms232315218.


References
1.
Smith-Vikos T, Slack F . MicroRNAs and their roles in aging. J Cell Sci. 2012; 125(Pt 1):7-17. PMC: 3269020. DOI: 10.1242/jcs.099200. View

2.
Wiedrick J, Phillips J, Lusardi T, McFarland T, Lind B, Sandau U . Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. J Alzheimers Dis. 2019; 67(3):875-891. PMC: 6687305. DOI: 10.3233/JAD-180539. View

3.
Zhao X, He X, Han X, Yu Y, Ye F, Chen Y . MicroRNA-mediated control of oligodendrocyte differentiation. Neuron. 2010; 65(5):612-26. PMC: 2855245. DOI: 10.1016/j.neuron.2010.02.018. View

4.
Gitler A, Dhillon P, Shorter J . Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017; 10(5):499-502. PMC: 5451177. DOI: 10.1242/dmm.030205. View

5.
Chen C, Zhong X, Smith D, Tai W, Yang J, Zou Y . Astrocyte-Specific Deletion of Sox2 Promotes Functional Recovery After Traumatic Brain Injury. Cereb Cortex. 2017; 29(1):54-69. PMC: 6659023. DOI: 10.1093/cercor/bhx303. View